The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome
Wolfram syndrome (WS) 1 is a rare monogenic neurodegenerative disorder caused by mutations in the gene encoding WFS1. Knowledge of the pathophysiology of WS is incomplete and to date, there is no treatment available. Here, we describe early deviations in the renin-angiotensin-aldosterone system (RAA...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90b4cfbac9b54ca78c5c3be13cf21805 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:90b4cfbac9b54ca78c5c3be13cf21805 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:90b4cfbac9b54ca78c5c3be13cf218052021-11-25T17:41:13ZThe Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome10.3390/genes121117172073-4425https://doaj.org/article/90b4cfbac9b54ca78c5c3be13cf218052021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4425/12/11/1717https://doaj.org/toc/2073-4425Wolfram syndrome (WS) 1 is a rare monogenic neurodegenerative disorder caused by mutations in the gene encoding WFS1. Knowledge of the pathophysiology of WS is incomplete and to date, there is no treatment available. Here, we describe early deviations in the renin-angiotensin-aldosterone system (RAAS) and bradykinin pathway (kallikrein kinin system, KKS) observed in a rat model of WS (<i>Wfs1</i> KO) and the modulative effect of glucagon-like peptide-1 receptor agonist liraglutide (LIR) and anti-epileptic drug valproate (VPA), which have been proven effective in delaying WS progression in WS animal models. We found that the expression of key receptors of the RAAS and KKS, <i>Agtr2</i> and <i>Bdkrb1</i>, were drastically downregulated both in vitro and in vivo at an early stage in a rat model of WS. Moreover, in <i>Wfs1</i>, KO serum aldosterone levels were substantially decreased and bradykinin levels increased compared to WT animals. Neither treatment nor their combination affected the gene expression levels seen in the <i>Wfs1</i> KO animals. However, all the treatments elevated serum aldosterone and decreased bradykinin in the <i>Wfs1</i> KO rats, as well as increasing angiotensin II levels independent of genotype. Altogether, our results indicate that <i>Wfs1</i> deficiency might disturb the normal functioning of RAAS and KKS and that LIR and VPA have the ability to modulate these systems.Marite PunapartKadri SeppaToomas JagomäeMailis LiivRiin ReimetsSilvia KirillovAllen KaasikLieve MoonsLies De GroefAnton TerasmaaEero VasarMario PlaasMDPI AGarticleWolfram syndrome<i>Wfs1</i><i>Wfs1</i> knock-outliraglutidevalproic acidRAASGeneticsQH426-470ENGenes, Vol 12, Iss 1717, p 1717 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Wolfram syndrome <i>Wfs1</i> <i>Wfs1</i> knock-out liraglutide valproic acid RAAS Genetics QH426-470 |
spellingShingle |
Wolfram syndrome <i>Wfs1</i> <i>Wfs1</i> knock-out liraglutide valproic acid RAAS Genetics QH426-470 Marite Punapart Kadri Seppa Toomas Jagomäe Mailis Liiv Riin Reimets Silvia Kirillov Allen Kaasik Lieve Moons Lies De Groef Anton Terasmaa Eero Vasar Mario Plaas The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome |
description |
Wolfram syndrome (WS) 1 is a rare monogenic neurodegenerative disorder caused by mutations in the gene encoding WFS1. Knowledge of the pathophysiology of WS is incomplete and to date, there is no treatment available. Here, we describe early deviations in the renin-angiotensin-aldosterone system (RAAS) and bradykinin pathway (kallikrein kinin system, KKS) observed in a rat model of WS (<i>Wfs1</i> KO) and the modulative effect of glucagon-like peptide-1 receptor agonist liraglutide (LIR) and anti-epileptic drug valproate (VPA), which have been proven effective in delaying WS progression in WS animal models. We found that the expression of key receptors of the RAAS and KKS, <i>Agtr2</i> and <i>Bdkrb1</i>, were drastically downregulated both in vitro and in vivo at an early stage in a rat model of WS. Moreover, in <i>Wfs1</i>, KO serum aldosterone levels were substantially decreased and bradykinin levels increased compared to WT animals. Neither treatment nor their combination affected the gene expression levels seen in the <i>Wfs1</i> KO animals. However, all the treatments elevated serum aldosterone and decreased bradykinin in the <i>Wfs1</i> KO rats, as well as increasing angiotensin II levels independent of genotype. Altogether, our results indicate that <i>Wfs1</i> deficiency might disturb the normal functioning of RAAS and KKS and that LIR and VPA have the ability to modulate these systems. |
format |
article |
author |
Marite Punapart Kadri Seppa Toomas Jagomäe Mailis Liiv Riin Reimets Silvia Kirillov Allen Kaasik Lieve Moons Lies De Groef Anton Terasmaa Eero Vasar Mario Plaas |
author_facet |
Marite Punapart Kadri Seppa Toomas Jagomäe Mailis Liiv Riin Reimets Silvia Kirillov Allen Kaasik Lieve Moons Lies De Groef Anton Terasmaa Eero Vasar Mario Plaas |
author_sort |
Marite Punapart |
title |
The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome |
title_short |
The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome |
title_full |
The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome |
title_fullStr |
The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome |
title_full_unstemmed |
The Expression of RAAS Key Receptors, <i>Agtr2</i> and <i>Bdkrb1</i>, Is Downregulated at an Early Stage in a Rat Model of Wolfram Syndrome |
title_sort |
expression of raas key receptors, <i>agtr2</i> and <i>bdkrb1</i>, is downregulated at an early stage in a rat model of wolfram syndrome |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/90b4cfbac9b54ca78c5c3be13cf21805 |
work_keys_str_mv |
AT maritepunapart theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT kadriseppa theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT toomasjagomae theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT mailisliiv theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT riinreimets theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT silviakirillov theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT allenkaasik theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT lievemoons theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT liesdegroef theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT antonterasmaa theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT eerovasar theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT marioplaas theexpressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT maritepunapart expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT kadriseppa expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT toomasjagomae expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT mailisliiv expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT riinreimets expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT silviakirillov expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT allenkaasik expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT lievemoons expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT liesdegroef expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT antonterasmaa expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT eerovasar expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome AT marioplaas expressionofraaskeyreceptorsiagtr2iandibdkrb1iisdownregulatedatanearlystageinaratmodelofwolframsyndrome |
_version_ |
1718412117625798656 |